Compare Neurocrine Biosciences Inc (NBIX) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Orion Office REIT Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Orion Office REIT Inc trades at $2.65 (market cap $150.60M). The key difference: Neurocrine Biosciences Inc is far larger — about 115.5× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.02% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | ONL | |
|---|---|---|
Market Cap | $17.40B | $150.60M |
Sector | Health | Real Estate |
52-Week High | $180.55 | $3.04 |
52-Week Low | $123.10 | $1.93 |
Enterprise Value | $16.49B | $634.25M |
Dividend Yield | — | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
